Company intelligence / Profile preview

Carnegie Pharmaceuticals LLC

Delran, New Jersey, United Statescarnegiepharma.com ↗

Ownership: Private
Employees: ~39
Development stage: Commercial

Overview

Carnegie Pharmaceuticals has successfully developed and received FDA approval for products including Clomipramine Hydrochloride Capsules (25 mg, 50 mg, and 75 mg)[4]. The company has completed its first FDA inspection and received DEA Manufacturing License for Schedule 2-5 substances[4].

Modalities: Generic and branded pharmaceutical products
Industry: Biotech

Drug pipeline

1 asset

Liothyronine Sodium Tablets

Unknown

Partnerships

Leading Pharma LLCAlter Pharma (Belgium)[4]

Beyond the preview

Go deeper on Carnegie Pharmaceuticals LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carnegie Pharmaceuticals LLC.

Explore the full profile